Literature DB >> 15780637

Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II.

Anna Di Fiore1, Giuseppina De Simone, Valeria Menchise, Carlo Pedone, Angela Casini, Andrea Scozzafava, Claudiu T Supuran.   

Abstract

N-1-(4-Sulfamoylphenyl)-N-4-pentafluorophenyl-thiosemicarbazide was prepared by the reaction of 4-isothiocyanato-benzenesulfonamide with pentafluorophenyl hydrazine, and proved to be an effective inhibitor of several isozymes of the zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1), such as CA I, II, and IX. Against the physiologically relevant isozymes hCA II and hCA IX, the compound showed inhibition constants in the range of 15-19 nM, whereas it was less effective as a hCA I inhibitor (K(I) of 78 nM). The high-resolution X-ray crystal structure of its adduct with hCA II showed the inhibitor to bind within the hydrophobic half of the enzyme active site, making extensive and strong van der Waals contacts with amino acid residues Gln92, Val121, Phe131, Leu198, Thr200, Pro202, in addition to the coordination of the sulfonamide nitrogen to the Zn(II) ion of the active site, and participation of the SO(2)NH(2) group to a network of hydrogen bonds involving residues Thr199 and Glu106. These results are helpful for the design of better CA II or CA IX inhibitors based on the thioureido-benzenesulfonamide motif, with potential applications as anti-glaucoma or anti-cancer drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15780637     DOI: 10.1016/j.bmcl.2005.01.086

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Metallotherapeutics: novel strategies in drug design.

Authors:  Lalintip Hocharoen; James A Cowan
Journal:  Chemistry       Date:  2009-09-07       Impact factor: 5.236

Review 2.  Carbonic anhydrase IX as a novel candidate in liquid biopsy.

Authors:  Ozen Ozensoy Guler; Claudiu T Supuran; Clemente Capasso
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.